MSB 4.52% 95.0¢ mesoblast limited

Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain, page-149

  1. 238 Posts.
    lightbulb Created with Sketch. 122
    Ha is not a standard treatment for CLBP, studies have shown mixed results as I am sure you know. I am also sure you know that it has been standard practice to use saline in the 'sham' arm of this blinded study. Where does the statement "Cells - effect but doesn't appear statistically significant" come from ? I thought you were a medical doctor, you are certainly not a statistician.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
-0.045(4.52%)
Mkt cap ! $1.084B
Open High Low Value Volume
$1.00 $1.01 94.5¢ $2.669M 2.769M

Buyers (Bids)

No. Vol. Price($)
1 2053 95.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.5¢ 13191 2
View Market Depth
Last trade - 16.10pm 20/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.